In many parts of the world, malaria elimination—defined by the World Health Organization (WHO) as the absence of locally acquired malaria cases in the country—is being considered as a target because of recent successes in reducing disease burden (1, 2). Rigorous evaluation of malaria elimination programs is essential for financial and political support to be maintained. Yet such evaluation remains challenging, and appropriate metrics to ascertain “success” are needed.
References and Notes
WHO, “Disease surveillance for malaria elimination: An operational manual” (WHO, Geneva, 2012).
WHO, “World malaria report: 2013” (WHO, Geneva, 2013).
Cohen J. M., Moonen B., Snow R. W., Smith D. L., Malar. J. 9, 213 (2010).
Hay S. I., Smith D. L., Snow R. W., Lancet Infect. Dis. 8, 369 (2008).
Kunene S., Phillips A. A., Gosling R. D., Kandula D., Novotny J. M., Malar. J. 10, 313 (2011).
Cauchemez S., et al., PLOS Med. 10, e1001399 (2013).
Hsiang M. S., et al., PLOS ONE 7, e29550 (2012).
Dureau J., Kalogeropoulos K., Baguelin M., Biostatistics 14, 541 (2013).
Smith D. L., Hay S. I., Noor A. M., Snow R. W., Trends Parasitol. 25, 511 (2009).
Volume 344 | Issue 6189
13 June 2014
13 June 2014
Copyright © 2014, American Association for the Advancement of Science.
Received: 28 January 2014
Accepted: 27 May 2014
Published in print: 13 June 2014
Request permissions for this article.
We thank the European Union (FP7-PREDEMICS); the National Institute of General Medical Sciences, NIH, MIDAS initiative; Labex Integrative Biology of Emerging Infectious Diseases; and Medical Research Council for financial support and the Swaziland Malaria Elimination Program for data collection.
Select the format you want to export the citation of this publication.
Download this article as a PDF fileDownload PDF